Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth
- 24 May 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (23) , 2937-2945
- https://doi.org/10.1038/sj.onc.1204422
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 41 references indexed in Scilit:
- Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin geneProceedings of the National Academy of Sciences, 2001
- Risk and prognosis of endometrial cancer after tamoxifen for breast cancerThe Lancet, 2000
- A brief review of the current breast cancer prevention trials and proposals for future trialsEuropean Journal Of Cancer, 2000
- Modulation of Endometrial Steroid Receptors and Growth Regulatory Genes by TamoxifenObstetrics & Gynecology, 2000
- Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia.Carcinogenesis: Integrative Cancer Research, 2000
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Adrenomedullin Gene Expression Is Developmentally Regulated and Induced by Hypoxia in Rat Ventricular Cardiac MyocytesPublished by Elsevier ,1998
- The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target.Cancer and Metastasis Reviews, 1998
- Tamoxifen and Endometrial NeoplasiaClinical Obstetrics and Gynecology, 1996
- Tamoxifen induced changes in MCF7 human breast cancer: In vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imagingThe Journal of Steroid Biochemistry and Molecular Biology, 1992